MedPath

A Study of E3810 for Japanese Subjects With Functional Dyspepsia(SAMURAI Study:Suppression of Acid Milieu with Rabeprazole Improving Functional Dyspepsia)

Phase 2
Conditions
Functional Dyspepsia
Registration Number
JPRN-jRCT2080221232
Lead Sponsor
Eisai Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
320
Inclusion Criteria

Subjects diagnosed as Functional Dyspepsia according to Rome III criteria.

Exclusion Criteria

-Subjects with neuropsychiatric disorder.
-Subjects diagnosed as IBS, IBD and serious constipation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Resolution rate of dispeptic symptom at last visit in treatment period
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath